DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betaseron (Interferon Beta-1B) - Current Clinical Trials

 
 



Betaseron Related Clinical Trials

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI [Active, not recruiting]

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron« to Treat Relapsing-remitting Multiple Sclerosis [Completed]

BEYOND Follow-up: Betaferon«/Betaseron« Efficacy Yielding Outcomes of a New Dose [Completed]

BENEFIT Study (Betaferon« / Betaseron« in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study [Completed]

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients [Completed]

Comparison Study of PF530 and Betaferon in Healthy Subjects [Active, not recruiting]

Natalizumab De-escalation With Interferon Beta-1b [Completed]

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis [Terminated]

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis [Completed]

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH) [Completed]

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Completed]

Rehabilitation Study in MS Patients [Terminated]

Physical Disability in Patients Treated With Betaferon [Completed]

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon« by Using Elements of the BetaPlus Program [Completed]

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period [Completed]

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors [Completed]

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis [Completed]

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron [Completed]

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon« in Korea [Withdrawn]

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon [Not yet recruiting]

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis [Active, not recruiting]

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. [Completed]

Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b [Completed]

Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy [Completed]

China Betaferon Adherence, Coping and Nurse Support Study [Active, not recruiting]

BAY86-5046 (Betaseron), Non Interventional Studies [Recruiting]

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis [Active, not recruiting]

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250┬Ág in Patients of Chinese Origin With Multiple Sclerosis [Completed]

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS [Completed]

Depression and Fatigue in MS Patients Treated With Betaferon. [Completed]

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen [Completed]

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Active, not recruiting]

RNF and Betaseron´┐Ż Tolerability Study [Completed]

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b [Completed]

Betaferon« Regulatory Post-Marketing Surveillance [Completed]

BEYOND Pilot Study [Completed]

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon [Recruiting]

Betaseron Pregnancy Registry [Completed]

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment [Completed]

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) [Withdrawn]

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Completed]

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [Terminated]

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon [Active, not recruiting]

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) [Recruiting]

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients [Completed]

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Active, not recruiting]

Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) [Completed]

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis [Completed]

Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif) [Active, not recruiting]

Physical Activity and Fatigue in Early Multiple Sclerosis (MS) [Completed]

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis [Terminated]

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis [Completed]

Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change [Completed]

A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis [Completed]

Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis [Completed]

BENEFIT Extension Study [Completed]

Therapy Optimization in Multiple Sclerosis (MS) [Completed]

Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [Recruiting]

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [Completed]

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [Completed]

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study [Recruiting]

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Active, not recruiting]

Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis [Completed]

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis (MS) After Failure on Other Therapies [Recruiting]

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis [Active, not recruiting]

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis [Not yet recruiting]

A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis [Completed]

A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability [Withdrawn]

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. [Completed]

Optimizing IFN Beta - 1B Dose [Completed]

Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015